Biocon Biologics insulins facility in Malaysia receives EU GMP Certification
The company has received the Certificate of GMP Compliance from the representative European inspection authority, Health Products Regulatory Authority (HPRA), Ireland.
The company has received the Certificate of GMP Compliance from the representative European inspection authority, Health Products Regulatory Authority (HPRA), Ireland.
This integrated, multi-product facility houses manufacturing suites, analytical testing laboratories and warehousing.
The expansion makes Exothera one of the largest viral vector facilities in Europe
The facility will manufacture its Herceptin biosimilar, Tuznue
The GMP certificate is valid for three years until April 2024.
The National IP Awards recognize outstanding contributions to India’s innovation economy through effective IP creation and commercialization
The site’s GMP Certification has been successfully renewed
Both units of Shilpa Medicare (Unit IV and Unit VII), have now received GMP approval from Eurasia
The company has received the GMP Certification after successful closure of the inspection
Subscribe To Our Newsletter & Stay Updated